Antiallodynic activity in oxaliplatin-induced diabetic neuropathy pain Albino Swiss mouse model assessed as reduced late-phase tactile allodynia at 30...

Basic Information

ID: ALA4767587

Type: Functional

Description: Antiallodynic activity in oxaliplatin-induced diabetic neuropathy pain Albino Swiss mouse model assessed as reduced late-phase tactile allodynia at 30 mg/kg, ip administered after 3 hrs of oxaliplatin stimulation and measured after 1 hr by van Frey test

Format: BAO_0000218

Organism: Mus musculus

Strain: Albino Swiss

Target:  Mus musculus(ALA375)

Document:  ALA4765247

Antiallodynic activity in oxaliplatin-induced diabetic neuropathy pain Albino Swiss mouse model assessed as reduced late-phase tactile allodynia at 30 mg/kg, ip administered after 3 hrs of oxaliplatin stimulation and measured after 1 hr by van Frey test: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
503.135.905.90